• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS RUBELLA IGG - IGG ANTIBODIES TO RUBELLA VIRUS; ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS RUBELLA IGG - IGG ANTIBODIES TO RUBELLA VIRUS; ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA Back to Search Results
Catalog Number 04618793190
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 05/15/2018
Event Type  malfunction  
Manufacturer Narrative
The event occurred in: (b)(6).
 
Event Description
The customer complained of questionable elecsys rubella igg (rub igg) immunoassay results for 3 separate samples from the same patient tested on a cobas e 411 immunoassay analyzer compared to the results from the elisa igg test method.On (b)(6) 2018 sample a rub igg result from the cobas e411 was 19.13 iu/ml, reactive.On (b)(6) 2018 sample b rub igg result from the cobas e411 was 19.09 iu/ml, reactive.On (b)(6) 2018 sample c rub igg result from the cobas e411 was 16.48 iu/ml, reactive.For samples a, b, and c the elisa igg test results were negative.The erroneous results were released outside of the laboratory to both the patient and their doctor.There was no allegation of an adverse event.The patient has no medical history of rubella disease or vaccination.The cobas e411 serial number was (b)(4).It was stated that the customer rarely runs qc testing.The customer had run qc testing on (b)(6) 2018 with acceptable results.From the information provided, it appears the rub igg reagent lot used for the (b)(6) 2018 result was lot 267421, and the rub igg reagent lot used for the (b)(6) 2018 results was lot 28366401 with an expiration date of 30-sep-2018.The investigation is currently ongoing.
 
Manufacturer Narrative
A new sample was drawn from the patient and the customer's rub igg result was "around 14 iu/ml" and was rubella igm negative.The sample was submitted for investigation and results comparable to the customer¿s results were obtained.The investigation is ongoing.
 
Manufacturer Narrative
The sample was investigated with the recomblot rubella test and was positive.A neutralization test successfully neutralized the sample, strongly supporting the rubella igg positive status of the sample.The positive sample result was correct.It was reactive in the elecsys rubella igg assay.The investigation did not identify a product problem.The cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RUBELLA IGG - IGG ANTIBODIES TO RUBELLA VIRUS
Type of Device
ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key7897455
MDR Text Key120982696
Report Number1823260-2018-03222
Device Sequence Number1
Product Code LFX
UDI-Device Identifier04015630921423
UDI-Public4015630921423
Combination Product (y/n)N
PMA/PMN Number
K072617
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup,Followup
Report Date 11/05/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number04618793190
Device Lot Number267421
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 09/04/2018
Initial Date FDA Received09/21/2018
Supplement Dates Manufacturer Received09/04/2018
09/04/2018
Supplement Dates FDA Received10/08/2018
11/05/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age29 YR
-
-